Physician
Famoyin, Charles
Famoyin, Charles was paid $271K by Medicaid between Jan 2018 and Dec 2020, across 38 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoFAMOYIN, CHARLES
JOHNSON CITY, TN 37601
JOHNSON CITY, TN 37601
33aNPI1003807355assigned 11/03/2005
33bProvider typeInternal Medicine Physician
28Total paid$271K
24GClaims38,753
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2020
Compared with peers
Next to other Internal Medicine Physician providers in Tennessee
Rank by total paid#92 of 581
Median peer was paid$15K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,707 | $103K | |
| 2019 | 11,924 | $85K | |
| 2020 | 11,122 | $83K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 3,499 | 2,802 | $92K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 21% | 2,941 | 1,521 | $58K |
| 96367 | 6.8% | 1,635 | 878 | $18K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 6.4% | 2,062 | 1,198 | $17K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4.5% | 1,850 | 1,105 | $12K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.5% | 628 | 541 | $12K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 4.4% | 1,148 | 610 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.1% | 1,692 | 1,426 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.0% | 3,799 | 3,053 | $11K |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | 2.1% | 1,557 | 695 | $6K |
| 83605 | 1.6% | 1,265 | 1,097 | $4K | |
| 80306 | 1.2% | 753 | 666 | $3K |
26 more codes
| 36415 | Collection of venous blood by venipuncture | 1.1% | 3,954 | $3K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.1% | 73 | $3K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 45 | $3K |
| 83735 | <1% | 1,247 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 973 | $713.56 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,103 | $499.28 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,358 | $423.91 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 979 | $370.68 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 705 | $253.93 |
| 80069 | <1% | 461 | $148.88 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 30 | $114.85 |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 51 | $70.24 |
| 82565 | <1% | 470 | $44.34 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 113 | $28.00 |
| 82947 | <1% | 456 | $21.10 | |
| 84520 | <1% | 463 | $18.79 | |
| 84295 | <1% | 465 | $10.52 | |
| 84132 | <1% | 462 | $10.07 | |
| 82040 | <1% | 470 | $6.80 | |
| 82310 | <1% | 471 | $4.75 | |
| 82374 | <1% | 463 | $4.53 | |
| 84100 | <1% | 468 | $4.35 | |
| 82435 | <1% | 465 | $4.25 | |
| 96523 | <1% | 113 | $3.30 | |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | <1% | 22 | $0.07 |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | <1% | 44 | $0.07 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.